MOST TRUSTED NEWSWIRE PRESS RELEASE DISTRIBUTION
PRTODAY / NewswireToday press release distribution service network
Written by / Agency / Source: Gold Biotechnology, Inc.
Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

GoldBio Launches New Product Line - Growth Factors and Stem Cell Reagents - Today in an email to customers, Bart Saracino, Marketing Director, announced the newest line of research products from Gold Biotechnology, Inc.: Growth Factors and Stem Cell Reagents - GoldBio.com
GoldBio Launches New Product Line - Growth Factors and Stem Cell Reagents

 

NewswireToday - /newswire/ - St. Louis, MO, United States, 2013/03/05 - Today in an email to customers, Bart Saracino, Marketing Director, announced the newest line of research products from Gold Biotechnology, Inc.: Growth Factors and Stem Cell Reagents - GoldBio.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

The Growth Factors and Stem Cell Reagents product line was developed over several months in collaboration with a major university in St. Louis. This move expands the GoldBio product portfolio, allowing the company to move into the area of stem cell research, a field where some of the most important biological processes are mediated. The company anticipates that this will be an area of continued growth for years to come, and that this product line will continue to be expanded throughout the year based on customer insight.

At the time of release, this new line consists of more than 35 widely used human, rat, and murine growth factors. The unique characteristics of the products include their extremely high quality, precise lot-to-lot consistency, and in keeping with the GoldBio brand, affordable price.

With the addition of this new line of products, GoldBio proudly adds its brand to the St. Louis area’s notable history with stem cell research. In the 1950s, Stanley Cohen and Rita Levi-Montalcini isolated nerve growth factor and then discovered epidermal growth factor at Washington University. They jointly received the Nobel Prize in Physiology or Medicine 1986 "for their discoveries of growth factors”. Research on cellular growth factors has proven fundamental to understanding the development of cancer and designing anti-cancer drugs.

About Gold Biotechnology, Inc.

Gold Biotechnology, Inc. was founded in 1986 by Dr. Paul Gold in an effort to provide researchers with high-quality reagents at a low price. A sustainable business model and unique relationships within the supply chain allow GoldBio to provide researchers and scientists with uniquely low prices while maintaining the highest quality in the industry. GoldBio.com now supplies more than 1,000 molecular and cell biology reagents to life and plant science researchers worldwide and has an active molecular biology research and development program.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Gold Biotechnology, Inc.

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick NewswireToday Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma / BioTech / Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


GoldBio Launches New Product Line - Growth Factors and Stem Cell Reagents

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name NewswireToday and LINK as the source.
 
Publisher Contact: Bart Saracino - GoldBio.com 
314-890-8778 bart.saracino[.]goldbio.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Gold Biotechnology, Inc. securities in any jurisdiction including any other companies listed or named in this release.

Pharma / BioTech / Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Gold Biotechnology, Inc. / Company Profile


Read Pharma / BioTech / Nutrition Most Recent Related Newswires:

Ipsen Data Presented During ENETS Annual Conference 2020 Capture New Patient and Healthcare Professional Insights in the Treatment of NETs
Global Pharmaceutical Contract Manufacturing Organization Market to Reach 2.14 Billion by 2024 Finds Frost & Sullivan
Ipsen’s Palovarotene Clinical Program in Fibrodysplasia Ossificans Progressiva Reaches Prespecified Interim Analysis Futility Criteria
Global Bio-based Chemicals Market is Expected to Grow At A CAGR of 16.67% by 2027 According to Inkwood Research
Global Diabetes Drugs Market Forecast 2019-2027 Reports Inkwood Research
Dysport® Now Approved in the UK for Symptomatic Treatment of Upper Limb Spasticity in Children with Cerebral Palsy
Human Microbiome Market to Reach .08 Billion by 2023, Powered by the High Growth in Over-the-Counter Probiotics Finds Frost & Sullivan
BASF Launches Hepacor in Switzerland for the Dietary Management of Non-Alcoholic Fatty Liver Disease
FDA Grants Priority Review to Genentech’s Risdiplam for Spinal Muscular Atrophy
Ipsen Presents New Analyses Utilizing Modern Data Mining Approaches At ISPOR Europe 2019
Global Opioids Drugs Market is Projected to Grow At a CAGR of 2.52% by 2027 Reports Inkwood Research
Global Bio-Based Chemicals Market Projected to Grow At a CAGR of 16.67% by 2027 Finds Inkwood Research
The Global Animal Nutrition Market Projected to Grow At a CAGR of 5.94% by 2027 Finds Inkwood Research
FDA Approves Genentech’s Rozlytrek (entrectinib) for People With ROS1-Positive, Metastatic Non-small Cell Lung Cancer
BTG to Invest in Chinese Medical Isotope Diagnosis and Treatment Company Chengdu New Radiomedicine Technology

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  Limelon Advertising, Co.

Visit  RightITnow, Inc.





 
  ©2020 NewswireToday — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com newswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)